
Circulating Fibroblast Growth Factor-21 Levels in Rheumatoid Arthritis: Associations With Disease Characteristics, Body Composition, and Physical Functioning
Author(s) -
Patrick Gould,
Babette S. Zemel,
Elena Taratuta,
Joshua F. Baker
Publication year - 2020
Publication title -
the journal of rheumatology/journal of rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.577
H-Index - 178
eISSN - 1499-2752
pISSN - 0315-162X
DOI - 10.3899/jrheum.200673
Subject(s) - medicine , rheumatoid arthritis , resistin , lean body mass , fibroblast growth factor 23 , risk factor , adipokine , endocrinology , gastroenterology , obesity , insulin resistance , body weight , parathyroid hormone , calcium
This study evaluated associations between fibroblast growth factor (FGF)-21, an adipokine associated with metabolic stress, and adverse longitudinal changes in body composition and physical functioning in patients with rheumatoid arthritis (RA).